BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 36432086)

  • 1. Machine Learning Models to Predict Protein-Protein Interaction Inhibitors.
    Díaz-Eufracio BI; Medina-Franco JL
    Molecules; 2022 Nov; 27(22):. PubMed ID: 36432086
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Computational models for the classification of mPGES-1 inhibitors with fingerprint descriptors.
    Xia Z; Yan A
    Mol Divers; 2017 Aug; 21(3):661-675. PubMed ID: 28484935
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparing Multiple Machine Learning Algorithms and Metrics for Estrogen Receptor Binding Prediction.
    Russo DP; Zorn KM; Clark AM; Zhu H; Ekins S
    Mol Pharm; 2018 Oct; 15(10):4361-4370. PubMed ID: 30114914
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Machine Learning Models Identify New Inhibitors for Human OATP1B1.
    Lane TR; Urbina F; Zhang X; Fye M; Gerlach J; Wright SH; Ekins S
    Mol Pharm; 2022 Nov; 19(11):4320-4332. PubMed ID: 36269563
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Machine learning-based modeling to predict inhibitors of acetylcholinesterase.
    Sandhu H; Kumar RN; Garg P
    Mol Divers; 2022 Feb; 26(1):331-340. PubMed ID: 33891263
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evolution of Support Vector Machine and Regression Modeling in Chemoinformatics and Drug Discovery.
    Rodríguez-Pérez R; Bajorath J
    J Comput Aided Mol Des; 2022 May; 36(5):355-362. PubMed ID: 35304657
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prediction of Orthosteric and Allosteric Regulations on Cannabinoid Receptors Using Supervised Machine Learning Classifiers.
    Bian Y; Jing Y; Wang L; Ma S; Jun JJ; Xie XQ
    Mol Pharm; 2019 Jun; 16(6):2605-2615. PubMed ID: 31013097
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HDAC3i-Finder: A Machine Learning-based Computational Tool to Screen for HDAC3 Inhibitors.
    Li S; Ding Y; Chen M; Chen Y; Kirchmair J; Zhu Z; Wu S; Xia J
    Mol Inform; 2021 Mar; 40(3):e2000105. PubMed ID: 33067876
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Discovering the Active Ingredients of Medicine and Food Homologous Substances for Inhibiting the Cyclooxygenase-2 Metabolic Pathway by Machine Learning Algorithms.
    Tian Y; Zhang Z; Yan A
    Molecules; 2023 Sep; 28(19):. PubMed ID: 37836625
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predicting Inhibitors for Multidrug Resistance Associated Protein-2 Transporter by Machine Learning Approach.
    Kharangarh S; Sandhu H; Tangadpalliwar S; Garg P
    Comb Chem High Throughput Screen; 2018; 21(8):557-566. PubMed ID: 30360705
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bioactivity Comparison across Multiple Machine Learning Algorithms Using over 5000 Datasets for Drug Discovery.
    Lane TR; Foil DH; Minerali E; Urbina F; Zorn KM; Ekins S
    Mol Pharm; 2021 Jan; 18(1):403-415. PubMed ID: 33325717
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Classification models and SAR analysis on HDAC1 inhibitors using machine learning methods.
    Li R; Tian Y; Yang Z; Ji Y; Ding J; Yan A
    Mol Divers; 2023 Jun; 27(3):1037-1051. PubMed ID: 35737257
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SAR study on inhibitors of GIIA secreted phospholipase A
    Zhang S; Li Y; Qin Z; Tu G; Chen G; Yan A
    Chem Biol Drug Des; 2019 May; 93(5):666-684. PubMed ID: 30582300
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Can machine learning predict pharmacotherapy outcomes? An application study in osteoporosis.
    Lin YT; Chu CY; Hung KS; Lu CH; Bednarczyk EM; Chen HY
    Comput Methods Programs Biomed; 2022 Oct; 225():107028. PubMed ID: 35930862
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacoprint: A Combination of a Pharmacophore Fingerprint and Artificial Intelligence as a Tool for Computer-Aided Drug Design.
    Warszycki D; Struski Ł; Śmieja M; Kafel R; Kurczab R
    J Chem Inf Model; 2021 Oct; 61(10):5054-5065. PubMed ID: 34547888
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Classification models and SAR analysis on thromboxane A
    Ji Y; Li R; Tian Y; Chen G; Yan A
    SAR QSAR Environ Res; 2022 Jun; 33(6):429-462. PubMed ID: 35678125
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Integrated Multi-Class Classification and Prediction of GPCR Allosteric Modulators by Machine Learning Intelligence.
    Hou T; Bian Y; McGuire T; Xie XQ
    Biomolecules; 2021 Jun; 11(6):. PubMed ID: 34208096
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluating machine learning-powered classification algorithms which utilize variants in the GCKR gene to predict metabolic syndrome: Tehran Cardio-metabolic Genetics Study.
    Akbarzadeh M; Alipour N; Moheimani H; Zahedi AS; Hosseini-Esfahani F; Lanjanian H; Azizi F; Daneshpour MS
    J Transl Med; 2022 Apr; 20(1):164. PubMed ID: 35397593
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A review on machine learning approaches and trends in drug discovery.
    Carracedo-Reboredo P; Liñares-Blanco J; Rodríguez-Fernández N; Cedrón F; Novoa FJ; Carballal A; Maojo V; Pazos A; Fernandez-Lozano C
    Comput Struct Biotechnol J; 2021; 19():4538-4558. PubMed ID: 34471498
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative analysis of machine learning approaches for predicting frequent emergency department visits.
    Safaripour R; June Lim HJ
    Health Informatics J; 2022; 28(2):14604582221106396. PubMed ID: 35686745
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.